نتایج جستجو برای: line chemotherapy

تعداد نتایج: 514303  

2014
Jangchul Park Hidekazu Yamaura Yasushi Yatabe Waki Hosoda Chiaki Kondo Junichi Shimizu Yoshitsugu Horio Kimihide Yoshida Kosuke Tanaka Tomoyo Oguri Yoshihisa Kobayashi Toyoaki Hida

Few articles have been published on the imaging findings of anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC). To investigate the radiological findings of ALK-positive NSCLC in the advanced stage, CT scans were examined. In addition, the response to chemotherapy was evaluated. Of the 36 patients with ALK-rearranged NSCLC, a mass and a nodule were identified in 17 (47....

ژورنال: مجله دندانپزشکی 1996
آقا حسینی, فرزانه , حیدری سراج, نیلوفر ,

Normal 0 false false false EN-US X-NONE AR-SA In recent years, Medical science has been developed remarkably in treatment of malignant diseases. New treatment modalities, chemotherapy, radiotherapy and immunotherapy in patients with different types of neoplasm have cured some cases and increased their life long. On the other hand, considerable comp...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2013
M Teo R S McDermott

We read with interest the recent report by Rahma et al. [1] on second-line chemotherapy in advanced pancreatic adenocarcinoma. The authors carried out a systematic analysis of second-line studies and found that second-line chemotherapy was associated with a survival advantage when compared with best supportive care. They also suggested that a gemcitabine– platinum combination might be superior ...

2017
Chiara Lazzari Alessandra Bulotta Monika Ducceschi Maria Grazia Viganò Elena Brioschi Francesca Corti Luca Gianni Vanesa Gregorc

Innovative therapeutic agents have significantly improved outcome with an acceptable safety profile in a substantial proportion of non-small cell lung cancer (NSCLC) patients, who depend on oncogenic molecular alterations for their malignant phenotype. Despite the survival improvement achieved with first-line chemotherapy, about 30% of patients do not obtain a tumor response. Moreover, those pa...

Journal: :galen medical journal 0
mohammad reza kandehkar ghahraman department of bacteriology and virology, school of medicine, shiraz university of medical sciences ,shiraz, iran razyeh hassanzadeh student research committee, shiraz university of medical sciences, shiraz, iran mohammad motamedifar shiraz hiv/aids research center (sharc) &department of bacteriology and virology, school of medicine,shiraz university of medical sciences ,shiraz, iran. abdolsamad ashrafzadeh department of urology,shiraz university of medical sciences ,shiraz, iran zahra hashemizadeh prof. alborzi clinical microbiology research center,shiraz university of medical sciences, shiraz, iran

background: methicillin-resistant (mrsa) staphylococcus aureus ( s. aureus ) are responsible for a vast number of nosocomial infections especially in immunocompromised subjects such as cancer patients. the presence of comorbidities including malignancies has been associated, with s. aureus bacteremia mortality. thus, the detection of mrsa in this patients and the antibiotic susceptibility patte...

Journal: :Journal of Cancer Metastasis and Treatment 2022

The approval of immune checkpoint inhibitors (ICIs) has changed the treatment landscape in many aspects urothelial cancer (UC), both non-muscle-invasive bladder and muscle-invasive introduced concept long-term remission for some patients metastatic setting. Front-line chemotherapy remains superior at achieving initial control disease compared to front-line therapy. However, durable responses ar...

2017
Se Hyun Kim Mi-Jung Kim Yu Jung Kim Hyun Chang Jin Won Kim Jeong-Ok Lee Keun-Wook Lee Jee Hyun Kim Soo-Mee Bang Jong Seok Lee

Paclitaxel has been shown to have clinical activity in the treatment of small cell lung cancer (SCLC). However, its role as third-line chemotherapy for SCLC after both etoposide- and camptothecin-based regimens has not been clarified.All patients with refractory SCLC who were treated with paclitaxel-based regimen as third-line chemotherapy between 2005 and 2011 in Seoul National University Bund...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011
Alessandra Gennari Martin Stockler Matteo Puntoni Mariapia Sormani Oriana Nanni Dino Amadori Nicholas Wilcken Mauro D'Amico Andrea DeCensi Paolo Bruzzi

PURPOSE To evaluate the effect of different first-line chemotherapy durations in patients with metastatic breast cancer (MBC) on overall survival (OS) and progression-free survival (PFS). METHODS We searched literature databases to identify randomized controlled trials that compared different chemotherapy durations in the first-line treatment of MBC. Only trials with unconfounded comparisons ...

2013
Hisashi Tanaka Takeshi Morimoto Kageaki Taima Yoshihito Tanaka Kunihiko Nakamura Akihito Hayashi Akira Kurose Ken Okumura Shingo Takanashi

BACKGROUND Thymic carcinoma is a rare neoplasm of the thymus. Systemic chemotherapy is an important therapeutic modality for thymic carcinoma. However, no standard chemotherapy for this carcinoma has yet been established. The usefulness of second-line or later-line chemotherapy has remained unclear. A case of relapsed thymic carcinoma that was successfully treated by S-1 as second-line chemothe...

Journal: :The New England journal of medicine 2005
Frances A Shepherd José Rodrigues Pereira Tudor Ciuleanu Eng Huat Tan Vera Hirsh Sumitra Thongprasert Daniel Campos Savitree Maoleekoonpiroj Michael Smylie Renato Martins Maximiliano van Kooten Mircea Dediu Brian Findlay Dongsheng Tu Dianne Johnston Andrea Bezjak Gary Clark Pedro Santabárbara Lesley Seymour

BACKGROUND We conducted a randomized, placebo-controlled, double-blind trial to determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival in non-small-cell lung cancer after the failure of first-line or second-line chemotherapy. METHODS Patients with stage IIIB or IV non-small-cell lung cancer, with performance status from 0 to 3, were eligible if they had r...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید